77 related articles for article (PubMed ID: 1656257)
21. Compatibility of granisetron hydrochloride with selected alkaline drugs.
Trissel LA; Martinez JF
Am J Health Syst Pharm; 1995 Jan; 52(2):208. PubMed ID: 12879553
[No Abstract] [Full Text] [Related]
22. Subcutaneous ondansetron.
Mulvenna PM; Regnard CF
Lancet; 1992 Apr; 339(8800):1059. PubMed ID: 1349087
[No Abstract] [Full Text] [Related]
23. pH in physiological salt solutions: direct measurements.
Abrahamsen J; Norrie B; Andersen PK; Stokke DB; Nedergaard OA
Acta Anaesthesiol Scand; 1990 Nov; 34(8):616-8. PubMed ID: 2177306
[TBL] [Abstract][Full Text] [Related]
24. [Examination of inhibitory effect, safety and usefulness of SN-307 (ondansetron) administered orally once daily for 3-5 consecutive days on nausea and emesis associated with non-platinum anti-cancer drugs].
Suminaga M; Furue H; Taguchi T; Ota K; Niitani H; Tsukagoshi S; Ariyoshi Y; Ikeda M; Akasaka Y; Ohta J
Gan To Kagaku Ryoho; 1992 Sep; 19(11):1891-903. PubMed ID: 1387775
[TBL] [Abstract][Full Text] [Related]
25. The use of sodium bicarbonate in neonatal resuscitation: help or harm?
Hein HA
Pediatrics; 1993 Feb; 91(2):496-7. PubMed ID: 8380926
[No Abstract] [Full Text] [Related]
26. [Examination of anti-emetic effect, safety and usefulness of single oral dose of ondansetron tablet in nausea and emesis induced by anti-cancer drugs--dose-finding study of ondansetron tablet in patients receiving non-platinum anti-cancer drugs].
Nukariya N; Niitani H; Taguchi T; Furue H; Ota K; Tsukagoshi S; Ariyoshi Y; Ikeda M; Akasaka Y; Ohta J
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1347-57. PubMed ID: 1386976
[TBL] [Abstract][Full Text] [Related]
27. [Clinical evaluation of ondansetron (injection of a single intravenous dose) against nausea and emesis associated with anti-cancer drugs--dose-finding study in patients receiving cisplatin].
Suminaga M; Furue H; Taguchi T; Ota K; Niitani H; Tsukagoshi S; Ariyoshi Y; Ikeda M; Ohta J; Akasaka Y
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1333-45. PubMed ID: 1386975
[TBL] [Abstract][Full Text] [Related]
28. Ondansetron to prevent vomiting after cancer chemotherapy.
Med Lett Drugs Ther; 1991 Jun; 33(847):63-4. PubMed ID: 1828531
[No Abstract] [Full Text] [Related]
29. [Anti-emetic effect and safety of consecutive use of ondansetron injection in cisplatin-induced nausea and emesis].
Akasaka Y; Taguchi T; Ota K; Furue H; Niitani H; Tsukagoshi S; Ariyoshi Y; Ikeda M; Ohta J; Suminaga M
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1359-74. PubMed ID: 1386977
[TBL] [Abstract][Full Text] [Related]
30. Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes.
Gungor S; Okyar A; Erturk-Toker S; Baktir G; Ozsoy Y
Drug Dev Ind Pharm; 2010 Jul; 36(7):806-13. PubMed ID: 20136490
[TBL] [Abstract][Full Text] [Related]
31. [Investigation of anti-emetic effect of ondansetron tablet in multiple doses on nausea and emesis associated with cisplatin].
Suminaga M; Furue H; Taguchi T; Niitani H; Ota K; Tsukagoshi S; Ariyoshi Y; Ikeda M; Akasaka Y; Ohta J
Gan To Kagaku Ryoho; 1992 Sep; 19(11):1879-90. PubMed ID: 1387774
[TBL] [Abstract][Full Text] [Related]
32. Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil.
Levitt M; Warr D; Yelle L; Rayner HL; Lofters WS; Perrault DJ; Wilson KS; Latreille J; Potvin M; Warner E
N Engl J Med; 1993 Apr; 328(15):1081-4. PubMed ID: 8455665
[TBL] [Abstract][Full Text] [Related]
33. Stability of an ofloxacin injection in various infusion fluids.
Bornstein M; Kao SH; Mercorelli M; Verma S
Am J Hosp Pharm; 1992 Nov; 49(11):2756-60. PubMed ID: 1335206
[TBL] [Abstract][Full Text] [Related]
34. Ondansetron (GR 38032F): a novel antiemetic effective in patients receiving a multiple-day regimen of cisplatin chemotherapy.
Hainsworth JD; Omura GA; Khojasteh A; Bryson JC; Finn AL
Am J Clin Oncol; 1991 Aug; 14(4):336-40. PubMed ID: 1830716
[TBL] [Abstract][Full Text] [Related]
35. Solution stability of cephradine neutralized with arginine or sodium bicarbonate.
Wang YC; Monkhouse DC
Am J Hosp Pharm; 1983 Mar; 40(3):432-4. PubMed ID: 6303120
[TBL] [Abstract][Full Text] [Related]
36. Interrelationships of chloride, bicarbonate, sodium, and hydrogen transport in the human ileum.
Turnberg LA; Bieberdorf FA; Morawski SG; Fordtran JS
J Clin Invest; 1970 Mar; 49(3):557-67. PubMed ID: 5415682
[TBL] [Abstract][Full Text] [Related]
37. Electrolyte compatibility in a synthetic amino acid hyperalimentation solution.
Kaminski MV; Harris DF; Collin CF; Sommers GA
Am J Hosp Pharm; 1974 Mar; 31(3):244-6. PubMed ID: 4206614
[No Abstract] [Full Text] [Related]
38. [Examination of anti-emetic effect and safety of multiple intravenous doses of ondansetron in patients receiving nonplatinum anti-cancer drugs].
Nukariya N; Niitani H; Taguchi T; Furue H; Ota K; Tsukagoshi S; Ariyoshi Y; Ikeda M; Akasaka Y; Ohta J
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1375-85. PubMed ID: 1386978
[TBL] [Abstract][Full Text] [Related]
39. Preparation of pH-adjusted local anesthetics.
Hinshaw KD; Fiscella R; Sugar J
Ophthalmic Surg; 1995; 26(3):194-9. PubMed ID: 7651682
[TBL] [Abstract][Full Text] [Related]
40. [Role of ondansetron in oncology].
Laplanche A; Gérondeau N
Bull Cancer; 1993 Jul; 80(7):568-76. PubMed ID: 8204937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
